Daniel Apel
Fortuna: 14 M $ al 30/06/2026
Fortuna: 14 M $ al 30/06/2026
Daniel J.
Apel is currently Director at Conceptus, Inc. since 2013, Director at Biotechnology Innovation Organization, and Chief Financial Officer at Arrowhead Pharmaceuticals, Inc. starting in 2025.
Formerly, Mr. Apel was Chief Financial Officer at Bayer Corp.
from 2016 to 2019 and Global Head-Financial Planning & Analysis at Walgreens Boots Alliance, Inc. from 2019 to 2024.
Education includes undergraduate studies at the University of Pennsylvania and an MBA from the University of California, Berkeley.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 06/01/2026 | 176.200 ( 0,13 % ) | 14 M $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Director Financiero/CFO | 13/05/2025 |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Director/Miembro de la Junta | - |
Conceptus, Inc.
Conceptus, Inc. Medical SpecialtiesHealth Technology Develops and markets minimally invasive devices for reproductive medical applications | Director/Miembro de la Junta | 05/06/2013 |
| Empresas | Cargo | Fin |
|---|---|---|
| WALGREENS BOOTS ALLIANCE, INC. | Corporate Officer/Principal | 01/01/2024 |
Bayer Corp.
Bayer Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical, healthcare & agricultural products | Director Financiero/CFO | 01/01/2019 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 7 |
|---|---|
Conceptus, Inc.
Conceptus, Inc. Medical SpecialtiesHealth Technology Develops and markets minimally invasive devices for reproductive medical applications | Health Technology |
Arrowhead Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drugs to treat intractable diseases | Health Technology |
Bayer Corp.
Bayer Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical, healthcare & agricultural products | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance, Inc. Drugstore ChainsRetail Trade Retails and wholesales pharmaceuticals & provides technology-enabled healthcare services | Retail Trade |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.